Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).

Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).

Item
http://www.wikidata.org/entity/Q33228157
Second-line treatment of metastatic gastric cancer: Current options and future directionsMitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives.Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective study.Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer.Second-line chemotherapy for patients with advanced gastric cancer.Latest developments and emerging treatment options in the management of stomach cancer.New perspectives in the treatment of advanced or metastatic gastric cancer.Activity of S-1 in advanced or recurrent gastric cancer patients after failure of prior chemotherapy, including irinotecan + cisplatin or fluorouracil (except S-1).Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas.Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways.Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer.
P2860

Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).

Item
http://www.wikidata.org/entity/Q33228157
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Irinotecan (CPT-11) and mitomy ...... alia Meridionale (prot. 2106).
@ast
Irinotecan (CPT-11) and mitomy ...... alia Meridionale (prot. 2106).
@en
type
label
Irinotecan (CPT-11) and mitomy ...... alia Meridionale (prot. 2106).
@ast
Irinotecan (CPT-11) and mitomy ...... alia Meridionale (prot. 2106).
@en
prefLabel
Irinotecan (CPT-11) and mitomy ...... alia Meridionale (prot. 2106).
@ast
Irinotecan (CPT-11) and mitomy ...... alia Meridionale (prot. 2106).
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Irinotecan (CPT-11) and mitomy ...... alia Meridionale (prot. 2106).
@en
P2093
P304
P31
P356
10.1097/01.COC.0000190398.52142.7F
P433
P478
P50
P577
P698